Tenofovir-induced kidney injury
- 16 March 2007
- journal article
- Published by Taylor & Francis in Expert Opinion on Drug Safety
- Vol. 6 (2) , 155-164
- https://doi.org/10.1517/14740338.6.2.155
Abstract
(2007). Tenofovir-induced kidney injury. Expert Opinion on Drug Safety: Vol. 6, No. 2, pp. 155-164. doi: 10.1517/14740338.6.2.155Keywords
This publication has 57 references indexed in Scilit:
- Mechanism of Active Renal Tubular Efflux of TenofovirAntimicrobial Agents and Chemotherapy, 2006
- Evaluation of hypophosphataemia in tenofovir disoproxil fumarate (TDF)‐exposed and TDF‐unexposed HIV‐infected out‐patients receiving highly active antiretroviral therapyHIV Medicine, 2006
- The role of drug interactions and monitoring in the prevention of tenofovir-associated kidney disease.Clinical Infectious Diseases, 2006
- Minor changes in calculated creatinine clearance and anion‐gap are associated with tenofovir disoproxil fumarate‐containing highly active antiretroviral therapyHIV Medicine, 2006
- Acute renal failure and Fanconi syndrome in an AIDS patient on tenofovir treatment—case report and review of literatureJournal of Infection, 2005
- Pharmacokinetics of Enfuvirtide in a Patient with Impaired Renal FunctionClinical Infectious Diseases, 2004
- Efficacy and Safety of Tenofovir DF vs Stavudine in Combination Therapy in Antiretroviral-Naive PatientsA 3-Year Randomized TrialJAMA, 2004
- Biological Effects of Short-Term or Prolonged Administration of 9-[2-(Phosphonomethoxy)Propyl]Adenine (Tenofovir) to Newborn and Infant Rhesus MacaquesAntimicrobial Agents and Chemotherapy, 2004
- Tenofovir Disoproxil FumarateDrugs, 2003
- Poor correlation between published methods to predict creatinine clearance and measured creatinine clearance in asymptomatic HIV infected individualsRenal Failure, 1998